About SpinaFX Medical

SpinaFX develops minimally invasive, image-guided medical devices that enhance precision in treatment delivery for various medical conditions. Their technology reduces patient recovery time and procedural risks compared to traditional surgical methods.

```xml <problem> Many patients with contained herniated discs experience back pain that does not respond to conservative treatments, yet they may not be ideal candidates for traditional surgical interventions like discectomy. This creates a therapeutic gap, leaving patients with limited options for effective and less invasive pain relief. </problem> <solution> SpinaFX Medical aims to fill the therapeutic gap in back pain treatment with Triojection, a minimally invasive, image-guided therapy for contained herniated discs. The Triojection system delivers a precise mixture of oxygen and ozone gas into the affected disc, reducing disc volume and related nerve pressure. This outpatient procedure is designed to provide rapid and sustained relief from back and leg pain, offering a less invasive alternative to surgery. The system consists of a computer-controlled console and a disposable single-use syringe with an ozone generation chamber, ensuring a sterile, metered, and accurate concentration of O2/O3 at the point of care. </solution> <features> - Minimally invasive, image-guided delivery of oxygen-ozone mixture into the disc nucleus - Computer-controlled console for precise ozone generation and spectroscopic measurement - Patented, disposable exterior case and syringe to maintain sterility during ozone delivery - High-quality O3 and UV-compatible disposable syringe polymers, including filters and stopcocks - Sterile, metered, measured, accurate, precise, and repeatable O2/O3 concentration at the point of care - Potential to reduce the number of patients requiring microdiscectomy for lumbar disc herniation leg pain </features> <target_audience> The primary target audience includes patients with contained herniated discs experiencing back and leg pain who have not responded to conservative therapies, as well as physicians and facilities seeking minimally invasive treatment options. </target_audience> ```

What does SpinaFX Medical do?

Where is SpinaFX Medical located?

SpinaFX Medical is based in Concord, United States.

When was SpinaFX Medical founded?

SpinaFX Medical was founded in 2021.

How much funding has SpinaFX Medical raised?

SpinaFX Medical has raised 9100000.

Location

Concord, United States

Founded

2021

Funding

9100000

Employees

10 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

SpinaFX Medical

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

spinafx.com 1K+

Crunchbase

Founded 2021 – Concord, United States

Funding

Estimated Funding

$5M+

Team (10+)

No team information available.

Company Description

Problem

Many patients with contained herniated discs experience back pain that does not respond to conservative treatments, yet they may not be ideal candidates for traditional surgical interventions like discectomy. This creates a therapeutic gap, leaving patients with limited options for effective and less invasive pain relief.

Solution

SpinaFX Medical aims to fill the therapeutic gap in back pain treatment with Triojection, a minimally invasive, image-guided therapy for contained herniated discs. The Triojection system delivers a precise mixture of oxygen and ozone gas into the affected disc, reducing disc volume and related nerve pressure. This outpatient procedure is designed to provide rapid and sustained relief from back and leg pain, offering a less invasive alternative to surgery. The system consists of a computer-controlled console and a disposable single-use syringe with an ozone generation chamber, ensuring a sterile, metered, and accurate concentration of O2/O3 at the point of care.

Features

Minimally invasive, image-guided delivery of oxygen-ozone mixture into the disc nucleus

Computer-controlled console for precise ozone generation and spectroscopic measurement

Patented, disposable exterior case and syringe to maintain sterility during ozone delivery

High-quality O3 and UV-compatible disposable syringe polymers, including filters and stopcocks

Sterile, metered, measured, accurate, precise, and repeatable O2/O3 concentration at the point of care

Potential to reduce the number of patients requiring microdiscectomy for lumbar disc herniation leg pain

Target Audience

The primary target audience includes patients with contained herniated discs experiencing back and leg pain who have not responded to conservative therapies, as well as physicians and facilities seeking minimally invasive treatment options.